Yuanquan Yang

Academic / Other · 2 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Ca Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8	Phase 2	2024-12-30
Recruiting	Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Recha Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm	Phase 2	2024-07-09